Dr. Michael Forte, MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- Northeastern Ohio University College of Medicine (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 258
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: Northeastern Ohio University College of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
OH license 35.141572 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Summa Health System Akron, OH
Medical groups
- Summa Physicians LLC (671 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 258
- Services billed
- 559
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 68 | 57 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 60 | 41 |
| Critical care, first 30-74 minutes | 59 | 31 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 53 | 42 |
| Test to examine how well the lungs exchange gases | 50 | 50 |
| Test to determine lung volumes using gas dilution or washout | 48 | 48 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 46 | 46 |
| New patient office or other outpatient visit, 45-59 minutes | 37 | 37 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 36 | 36 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Akron, OH | 228 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Akron, OH | 222 |
| Prednisone Other prescribers in Akron, OH | 83 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Akron, OH | 70 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Akron, OH | 67 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Akron, OH | 64 |
| Montelukast Sodium Other prescribers in Akron, OH | 46 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Akron, OH | 44 |
| Dupixent Pen (dupilumab) Other prescribers in Akron, OH | 41 |
| Azithromycin Other prescribers in Akron, OH | 41 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 52 payments worth $6,142 in total to this clinician.
| Verona Pharma, Inc. | $3,457 |
|---|---|
| Pulmonx Corporation | $2,170 |
| GlaxoSmithKline, LLC. | $212 |
| Fisher & Paykel Healthcare Inc | $86.95 |
| Amgen Inc. | $42.40 |
| Mallinckrodt Hospital Products Inc. | $38.53 |
| United Therapeutics Corporation | $37.72 |
| AstraZeneca Pharmaceuticals LP | $28.00 |
| Honoraria | $2,500 |
|---|---|
| Food and Beverage | $1,671 |
| Travel and Lodging | $995 |
| Education | $775 |
| Consulting Fee | $200 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Verona Pharma, Inc. Sep 10, 2025 | Honoraria Ohtuvayre · Pulmonary/Respiratory Diseases | $2,500 |
| Pulmonx Corporation Aug 14, 2025 | Travel and Lodging PULMONX CHARTIS TABLET CONSOLE; ZEPHYR DELIVERY CATHETER; CHARTIS CATHETER · PULMONOLOGY · travel to DENVER, CO | $556 |
| Verona Pharma, Inc. Feb 25, 2025 | Education Ohtuvayre · Pulmonary/Respiratory Diseases | $400 |
| Verona Pharma, Inc. Mar 10, 2025 | Education Ohtuvayre · Pulmonary/Respiratory Diseases | $375 |
| Pulmonx Corporation Sep 19, 2025 | Travel and Lodging ZEPHYR ENDOBRONCHIAL VALVE; PULMONX CHARTIS TABLET CONSOLE; CHARTIS CATHETER · PULMONOLOGY · travel to DENVER, CO | $288 |
| Pulmonx Corporation Oct 8, 2025 | Consulting Fee PULMONX CHARTIS TABLET CONSOLE; CHARTIS CATHETER; ZEPHYR DELIVERY CATHETER · PULMONOLOGY | $200 |
| Pulmonx Corporation Oct 29, 2025 | Travel and Lodging ZEPHYR ENDOBRONCHIAL VALVE; ZEPHYR DELIVERY CATHETER; CHARTIS CATHETER · PULMONOLOGY · travel to DENVER, CO | $151 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.